NCT06519162 Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
| NCT ID | NCT06519162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chungnam National University Hospital |
| Condition | Autoimmune Hepatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-07-08 |
| Primary Completion | 2029-07-08 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Eligibility Criteria
Inclusion Criteria: * Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital. * Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital. B. Exclusion Exclusion Criteria: * Individuals under the age of 19. * Patients or guardians who do not consent to participate in the study